<DOC>
	<DOCNO>NCT00959075</DOCNO>
	<brief_summary>Background : Patients heart failure ( HF ) increase risk develop thiamin deficiency ( TD ) . Thiamin ( vitamin B1 ) require production energy therefore TD may contribute energy depletion commonly observe failing heart . Thiamin supplementation trial date show conflict result therefore study explain impact thiamin supplementation HF patient TD necessary . Objective : The purpose study determine whether thiamin supplementation ambulatory cohort patient systolic heart failure provide benefit term improve heart function , symptom , exercise capacity , quality life . Description : Patients involve study give either thiamin supplement match placebo ( pill contain thiamin ) 6 month . The ability heart pump supplementation measure use cardiac magnetic resonance imaging ( MRI ) and/or 3D echocardiography . Relevance : This study determine whether thiamin supplementation improve cardiac function , exercise tolerance quality life . Thiamin supplementation widely available , inexpensive , safe . Therefore trial may major impact optimal management expand population heart failure patient .</brief_summary>
	<brief_title>A Trial Thiamin Supplementation Patients With Heart Failure</brief_title>
	<detailed_description>Background : There accumulate evidence patient heart failure ( HF ) high prevalence thiamin deficiency ( TD ) . Since thiamin key cofactor enzyme system produce energy carbohydrate fat , TD may contribute energy depletion frequently observe failing heart . Altered energy reserve reduction myocardial ATP recognize play critical role development progression HF . Therefore , correction TD may enhance cardiac energy substrate availability utilization , lead improvement ventricular function symptom . Primary Hypothesis : The left ventricular ejection fraction stable , ambulatory patient systolic heart failure receive 6 month oral thiamin supplementation significantly high comparison receive placebo . Secondary Hypothesis : In heart failure patient oral thiamin supplementation 1 ) favourable effect ventricular remodelling ( reduction diastolic systolic volume ) regional function ; 2 ) reduce neurohormonal stimulation ( BNP norepinephrine ) well oxidative stress ; 3 ) improve exercise capacity 4 ) improve symptom quality life . Ambulatory patient attend heart failure clinic Mount Sinai , University Health Network , Trillium Health Centre St. Michael 's Hospital systolic heart failure ( NYHA class II-IV , leave ventricular ejection fraction &lt; 45 % ) screen eligibility participate randomize trial . We randomize seventy eligible patient use stratified , permuted block randomization scheme , give either 100mg BID thiamin HCl match placebo BID 1:1 ratio take six month . All study personnel blind treatment assignment . Participants baseline follow-up visit include collect demographic data , history medication use , symptom , anthropometrics well physical exam . Left ventricular ejection fraction , volume , regional function measure use standardize echocardiogram cardiac MRI baseline six month supplementation . At time , blood marker thiamin status , oxidative stress ( F2 isoprostanes ) neurohormonal activation ( norepinephrine BNP ) also measure . Participants also complete six-minute walk test , 3-day dietary record , Living Heart Failure quality life instrument 24-hour urine collection ( measure urinary thiamin excretion ) baseline follow-up visit . Compliance measure use return pill count verified measure plasma thiamin level respond rapidly thiamin supplementation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>primary diagnosis ischemic , dilate , idiopathic valvular heart failure characterize ejection fraction &lt; 45 % ( echocardiography radionuclide scan ) optimize medication regimen ( ACE inhibitor angiotensin receptor blocker , beta blocker target dos , uptitrated maximum dos tolerate ) stable ( current medication regimen hospitalization acute decompensated heart failure &gt; 2 month ) prior entry study Participants exclude : unable unwilling provide inform consent concurrent condition would result thiamin deficiency , namely gastrointestinal disorder , magnesium deficiency , liver disease , thyrotoxicosis , B12 deficiency , folate deficiency , prolonged diarrhoeal disease , dialysis , prolong fever infection , recent myocardial infarction , coronary revascularization ( percutaneous coronary intervention coronary artery bypass surgery within 3 month ) , renal failure rapidly deteriorate , stable medication regimen ( 2 month ) hospitalize acute decompensated heart failure last 2 month experimental medication take vitamin supplement contain thiamin &gt; 10mg/day consume excessive alcohol ( &gt; 3 drink per day ) , document history alcoholism document alcoholic cardiomyopathy permanent atrial fibrillation pregnant would like become pregnant righttoleft , bidirectional , transient right leave cardiac shunt clinically suspect wet Beri Beri opinion treat physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Thiamin supplementation</keyword>
	<keyword>Thiamin deficiency</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Improve heart function</keyword>
	<keyword>Vitamin B1 supplementation</keyword>
</DOC>